Multinational pharmaceutical firms are changing strategies and selling business lines, as a government bulk-buying program favors cheaper, local products.

[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market

<p>China Stories from the Sinica Network on The China Project brings you audio narration of the best articles and op-eds appearing in Sixth Tone, Caixin Global, Week in China, The World of Chinese, and of course The China Project. Subscribe to the podcast and you can listen to features on the go, with narrators who won’t butcher the pronunciation of Chinese names and words.</p>

News

News Commentary

Politics

China Stories from the Sinica Network on The China Project brings you audio narration of the best articles and op-eds appearing in Sixth Tone, Caixin Global, Week in China, The World of Chinese, and of course The China Project. Subscribe to the podcast and you can listen to features on the go, with narrators who won’t butcher the pronunciation of Chinese names and words.

Share [Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market

Sign up to save your podcasts

[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market

[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market